Why is Aristo Bio-Tech falling/rising?

As of 14-Jul, Aristo Bio-Tech & Lifescience Ltd is currently priced at 128.40, reflecting a decrease of 2.6, or 1.98%. The stock has shown a performance today that outperformed its sector by 0.5%. However, it has experienced a significant decline in investor participation, with delivery volume dropping by 73.68% compared to the 5-day average. In terms of returns, the stock has seen a 7.76% decline over the past week, while it has increased by 13.13% over the past month. Year-to-date, the stock is down 3.46%, but it has gained 24.42% over the past year. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.
Broader Market Context: In comparison to the benchmark, the Sensex has only declined by 1.49% over the past week, indicating that Aristo Bio-Tech's short-term performance is lagging behind the broader market. While the stock has outperformed the sector today, its overall year-to-date performance is underwhelming compared to the Sensex's 6.08% gain. This suggests that while there may be some positive momentum in the short term, the stock's recent decline and lower investor participation could be contributing to its overall weaker performance relative to the market.